Industrial symposium – Moderna Germany GmbH
Respiratory Syncytial Virus (RSV): Understanding disease burden and mRNA vaccine research pathways

Programme

• 12:15 – 12:20 5 Min. 0 Min.

  • Industrial talk

  Introduction

  • Dr. Emilio Fumero (Basel / CH)
• 12:20 – 12:40 20 Min. 0 Min.

  • Industrial talk

  Prevention of Respiratory Syncytial Virus (RSV) infections

  • Prof. Dr. Martina Prelog (Wuerzburg / DE)
• 12:40 – 12:45 0 Min. 5 Min.

  • Discussion

  Discussion
• 12:45 – 13:05 20 Min. 0 Min.

  • Industrial talk

  Advances in mRNA Vaccine Adaptation: Responding to Emerging Virus Variants

  • Dr. Andrea Carfi (Cambridge, MA / US)
• 13:05 – 13:15 0 Min. 10 Min.

  • Discussion

  Discussion & Wrap-Up